DERMATOLOGIC ADVERSE EVENTS WITHIN THE FIRST 60 DAYS OF SORAFENIB TREATMENT ARE ASSOCIATED WITH BETTER OVERALL SURVIVAL (OS) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)

被引：0
|
作者：
Reig, M. [1 ]
Rodriguez de Lope, C. [1 ]
Llarch, N. [1 ]
Forner, A. [1 ]
Torres, F. [2 ]
Rios, J. [2 ]
Boix, L. [1 ]
Rimola, J. [3 ]
Darnell, A. [3 ]
Ayuso, C. [3 ]
Bruix, J. [1 ]
机构：
[1] Univ Barcelona, BCLC Grp, Liver Unit, CIBERehd,IDIBAPS,Hosp Clin, Barcelona, Spain
[2] Univ Autonoma Barcelona, IDIBAPS, Hosp Clin Barcelona, Unidad Bioestadist,Fac Med, E-08193 Barcelona, Spain
[3] Univ Barcelona, BCLC Grp, Dept Radiol, CIBERehd,IDIBAPS,Hosp Clin, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60269-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
267
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [41] The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Campani, Claudia
    Colagrande, Stefano
    Calistri, Linda
    Lorini, Chiara
    Castellani, Alessandro
    Marra, Fabio
    JOURNAL OF HEPATOLOGY, 2020, 73 : S896 - S897
  • [42] Trans-arterial chemoembolization with sorafenib treatment improves long-term overall survival of patients with intermediate hepatocellular carcinoma
    Yao, Zhen
    Hao, Weiyuan
    Guo, Liwen
    Zeng, Hui
    Chen, Yutang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10569 - 10578
  • [43] Association of objective response by mRECIST with better overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with systemic therapies: A systematic review and meta-analysis of randomized controlled trials
    Kudo, Masatoshi
    Chiba, Yasutaka
    Meyer, Tim
    Lencioni, Riccardo
    Llovet, Josep M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [44] A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy
    Gillet, Jean-Pierre
    Andersen, Jesper B.
    Madigan, James P.
    Varma, Sudhir
    Bagni, Rachel K.
    Powell, Katie
    Burgan, William E.
    Wu, Chung-Pu
    Calcagno, Anna Maria
    Ambudkar, Suresh V.
    Thorgeirsson, Snorri S.
    Gottesman, Michael M.
    MOLECULAR PHARMACOLOGY, 2016, 89 (02) : 263 - 272
  • [45] Update on overall survival (OS) of RESCUE: An open-label, phase 2 trial of camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (HCC).
    Zhang, Yun
    Xu, Jianming
    Shen, Jie
    Gu, Shanzhi
    Wu, Lihua
    Wu, Jian
    Shao, Guoliang
    Zhang, Yanqiao
    Xu, Li
    Yin, Tao
    Liu, Jingfeng
    Ren, Zhenggang
    Xiong, Jianping
    Mao, Xianhai
    Zhang, Ling
    Yang, Jiayin
    Li, Lequn
    Chen, Xiaoming
    Wang, Zhiming
    Wang, Quanren
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Overall survival (OS) in patients (pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): A real-world retrospective study.
    Hennenfent, Kristin L.
    Girvan, Allicia C.
    Chaudhry, Aafia
    Abada, Paolo
    Sheffield, Kristin
    Herren, Catherine K.
    Raju, Aditya
    Farrelly, Eileen
    Bowman, Lee
    Landsman-Blurnberg, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] OVERALL SURVIVAL IN INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS AFTER FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE): PROPOSAL OF A NEW SCORING SYSTEM
    Sacco, R.
    Ginanni, B.
    Mismas, V.
    Masi, G.
    De Simone, P.
    Romano, A.
    Bresci, G.
    Bartolozzi, C.
    Bargellini, I.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E44 - E44
  • [48] OVERALL SURVIVAL IN INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS AFTER FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE): PROPOSAL OF A NEW SCORING SYSTEM
    Sacco, R.
    Ginanni, B.
    Masi, G.
    De Simone, P.
    Bresci, G.
    Bartolozzi, C.
    Bargellini, I.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E183 - E184
  • [49] Implementation of a Voice Messaging System is Associated With Improved Time-to-Treatment and Overall Survival in Patients With Hepatocellular Carcinoma
    Mokdad, Ali
    Browning, Travis
    Mansour, John C.
    Zhu, Hao
    Singal, Amit G.
    Yopp, Adam C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (01): : 38 - 46
  • [50] IMPROVED TREATMENT DELIVERY AND OVERALL SURVIVAL ASSOCIATED WITH MULTIDISCIPLINARY TUMOR BOARD EVALUATION OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Zou, Winnie Y.
    Temple, Sarah
    Sada, Yvonne H.
    El-Serag, Hashem B.
    May, Sarah B.
    Kanwal, Fasiha
    Richardson, Peter
    Anaya, Daniel A.
    Davila, Jessica
    GASTROENTEROLOGY, 2018, 154 (06) : S1236 - S1236
12345